
CPHI India 2026
11/2026 – 11/2026
A new-age company founded to develop and manufacture niche APIs, Cleargreens Pharmaceuticals leverages its leadership team's long, successful experience to deliver efficient, cost-effective development of complex APIs, achieving strong market presence in select exclusive APIs within just two years. With a robust development pipeline and a stringent quality culture, the company also develops and manufactures exclusively for partners, with products including alpha catalogue amino acids, ferric carboxymaltose, palmitoylethanolamide, N(2)-L-alanyl-L-glutamine, iron sucrose, cilostazol, levetiracetam, citicoline sodium, mycophenolate mofetil, aripiprazole and ferric citrate.

コメントはありません。
評価とコメントを残す